Skip to main content
AAO-HNSF 2025 Annual Meeting & OTO EXPO Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Expert Lectures

Head and Neck Surgery

Evidenced-Based Approach to Oropharynx Cancer, 2025

Sunday, October 12, 2025
9:30 AM - 10:30 AM EDT
Location: 126
Disclosure(s):
Neil D D. Gross, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

PROGRAM DESCRIPTION: HPV-associated oropharynx squamous cell carcinoma (OPSCC) is now one of the most common cancers faced by the Otolaryngology community. Treatment strategies for these patients continue to evolve rapidly because of new technologies including intensity-modulated proton therapy (IMPT), neoadjuvant systemic approaches utilizing immunotherapy, transoral robotic surgery (TORS) and other novel de-escalation strategies. Current treatment approaches vary widely among institutions and national consensus guidelines remain vague. This expert lecture series will review the current best evidence to guide management decisions relevant to general otolaryngologists and head and neck specialists alike with a focus on evidenced-based multidisciplinary management.

OUTCOME OBJECTIVE 1: To understand recent advances in the treatment of oropharynx squamous cell carcinoma (OPSCC).

OUTCOME OBJECTIVE 2: To describe the current evidence supporting treatment strategies for OPSCC.

OUTCOME OBJECTIVE 3: To understand the rational application of potential de-escalation strategies to OPSCC.

BACKGROUND STATEMENT: Management of oropharynx squamous cell carcinoma (OPSCC) continues to evolve, and otolaryngologists can be challenged to stay current. This expert lecture will review contemporary best evidence to support the contemporary treatment of OPSCC.

Comprehensive Otolaryngology Track Statement : The incidence of HPV-associated OPSCC is one of the most common cancers diagnosed in the US. Otolaryngologists will diagnose and manage the majority of these patients. Thus, up-to-date information on the management of OPSCC is critical to the general otolaryngology community.

    Lead Presenter(s)

  • NG

    Neil D D. Gross, MD

    Professor
    MD Anderson Cancer Center
    Houston, TX, United States

    Disclosure(s):

    faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

    • Co-Presenter(s)

  • kV

    kathryn M. Van Abel, MD

    Professor
    Mayo Clinic Department of Otolaryngology- Head & Neck Surgery
    Rochester, Minnesota, United States

    Disclosure information not submitted.

    • Mentor(s)

  • CH

    Chris Holsinger, MD, FACS

    Professor and Chief HN Surgical Oncology
    Department of Otolaryngology - Head & Neck Surgery, Stanford University
    Stanford, CA, United States

    Disclosure information not submitted.